0

    543500

    EVOQ

    img img img img
    No Data Available

    Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply

    Evoq Remedies Limited Share Price Today

    Investment Returns

    Over 1 Month -10.81% Over 3 Months -31.45% Over 6 Months -20.61% Over 1 Year -50.53%
    demotext Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

    Evoq Remedies Limited fundamentals


    • Market cap (Cr) [-]
    • P/E Ratio (TTM) [-]
    • Beta [-]
    • Book Value / share [-]
    • Return on equity [-]%
    • EPS (TTM) [-]
    • Dividend yield [-]%
    • Net profit/quarter (Cr) [-]
    info icon alternate text
    • Market cap (Cr) 5.30
    • P/E Ratio (TTM) -22.50
    • Beta 1.28
    • Book Value / share 17.79
    • Return on equity 0.26%
    • EPS (TTM) 0.00
    • Dividend yield [-]%
    • Net profit/quarter (Cr) 0.00
    info icon alternate text

    Evoq Remedies Limited Financials

    • Key Results
    • Key Ratios
    • Balance sheet
    • Cash Flow
    • Competition
    Open financial information
    Revenue
    Net income
    Particulars MAR 2026 (Values in Cr)
    Revenue 25.51
    Operating Expense 27.01
    Net Profit -0.24
    Net Profit Margin (%) -0.94
    Earnings Per Share (EPS) -0.10
    EBITDA -0.20
    Effective Tax Rate (%) 4.00
    Particulars MAR 2025 (Values in Cr)
    Revenue 11.76
    Operating Expense 14.04
    Net Profit 0.09
    Net Profit Margin (%) 0.76
    Earnings Per Share (EPS) 0.04
    EBITDA 0.18
    Effective Tax Rate (%) 30.76
    Particulars MAR 2024 (Values in Cr)
    Revenue 4.05
    Operating Expense 5.70
    Net Profit 0.45
    Net Profit Margin (%) 11.11
    Earnings Per Share (EPS) 0.33
    EBITDA 0.62
    Effective Tax Rate (%) 26.22
    Particulars MAR 2023 (Values in Cr)
    Revenue 20.39
    Operating Expense 24.13
    Net Profit 1.62
    Net Profit Margin (%) 7.94
    Earnings Per Share (EPS) 1.19
    EBITDA 2.28
    Effective Tax Rate (%) 29.38
    Particulars MAR 2022 (Values in Cr)
    Revenue 16.78
    Operating Expense 15.32
    Net Profit 1.09
    Net Profit Margin (%) 6.49
    Earnings Per Share (EPS) 0.70
    EBITDA 1.46
    Effective Tax Rate (%) 25.34
    Particulars MAR 2025 (Values in Cr)
    Book Value / Share 17.89
    ROE % 0.26
    ROCE % 0.35
    Total Debt to Total Equity 0.06
    EBITDA Margin 1.53
    Particulars MAR 2024 (Values in Cr)
    Book Value / Share 18.56
    ROE % 1.80
    ROCE % 1.91
    Total Debt to Total Equity 0.28
    EBITDA Margin 15.31
    Particulars MAR 2023 (Values in Cr)
    Book Value / Share 18.22
    ROE % 6.76
    ROCE % 6.97
    Total Debt to Total Equity 0.37
    EBITDA Margin 11.23
    Particulars MAR 2022 (Values in Cr)
    Book Value / Share 17.03
    ROE % 9.12
    ROCE % 9.11
    Total Debt to Total Equity 0.34
    EBITDA Margin 8.70
    Particulars MAR 2021 (Values in Cr)
    Book Value / Share 743.02
    ROE % 189.47
    ROCE % 249.35
    Total Debt to Total Equity 0.01
    EBITDA Margin 9.48
    Particulars MAR 2025 (Values in Cr)
    Cash & Short Term Investments 0.21
    Total Assets 50.00
    Total Liabilities 50.00
    Total Equity 44.53
    Share Outstanding 2
    Price to Book Ratio 0.14
    Return on Assets (%) 0.17
    Return on Capital (%) 0.2
    Particulars MAR 2024 (Values in Cr)
    Cash & Short Term Investments 0.12
    Total Assets 36.86
    Total Liabilities 36.86
    Total Equity 25.23
    Share Outstanding 1
    Price to Book Ratio 0.47
    Return on Assets (%) 1.22
    Return on Capital (%) 1.53
    Particulars MAR 2023 (Values in Cr)
    Cash & Short Term Investments 0.15
    Total Assets 34.89
    Total Liabilities 34.89
    Total Equity 24.78
    Share Outstanding 1
    Price to Book Ratio 0.71
    Return on Assets (%) 4.64
    Return on Capital (%) 4.71
    Particulars MAR 2022 (Values in Cr)
    Cash & Short Term Investments 3.09
    Total Assets 33.33
    Total Liabilities 33.33
    Total Equity 23.16
    Share Outstanding 1
    Price to Book Ratio 1.33
    Return on Assets (%) 3.27
    Return on Capital (%) 3.48
    Particulars MAR 2021 (Values in Cr)
    Cash & Short Term Investments 0.03
    Total Assets 8.04
    Total Liabilities 8.04
    Total Equity 0.74
    Share Outstanding 0
    Price to Book Ratio 0.00
    Return on Assets (%) 8.89
    Return on Capital (%) 96.13
    Particulars MAR 2025 (Values in Cr)
    Net Income 0.12
    Cash from Operations -14.58
    Cash from Investing -0.25
    Cash from Financing 14.97
    Net change in Cash 0.09
    Free Cash Flow -14.32
    Particulars MAR 2024 (Values in Cr)
    Net Income 0.61
    Cash from Operations 5.47
    Cash from Investing -0.01
    Cash from Financing -5.33
    Net change in Cash -0.03
    Free Cash Flow 5.49
    Particulars MAR 2023 (Values in Cr)
    Net Income 2.28
    Cash from Operations -3.67
    Cash from Investing -0.01
    Cash from Financing 1.41
    Net change in Cash -2.94
    Free Cash Flow -3.66
    Particulars MAR 2022 (Values in Cr)
    Net Income 1.45
    Cash from Operations -26.05
    Cash from Investing 0.00
    Cash from Financing 29.49
    Net change in Cash 3.06
    Free Cash Flow -26.05
    Particulars MAR 2021 (Values in Cr)
    Net Income 0.71
    Cash from Operations 0.03
    Cash from Investing 0.00
    Cash from Financing 0.00
    Net change in Cash 0.03
    Free Cash Flow 0.03
    Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
    AEGIS LOGISTICS LTD. 1294.20 50.57 7.50 45426.42 576.00 1421.90
    KOTHARI INDUSTRIAL CORP L 175.50 0.00 9.05 1895.78 142.00 624.95
    OSWAL AGRO MILLS LTD 40.75 0.00 0.60 546.99 33.50 94.50
    DHUNSERI VENTURES LIMITED 244.70 9.40 0.26 856.94 176.20 386.10
    RAMA PETROCHEMICALS LTD. 16.00 0.00 -0.38 24.67 12.05 16.92
    Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
    AEGIS LOGISTICS LTD. 1294.20 48.15 13.13 45426.42 576.00 1421.90
    UTIQUE ENTERPRISES LIMITED 3.77 11.09 0.29 20.99 3.20 6.40
    COMPUTER POINT LTD. 3.78 0.00 0.34 11.34 3.39 6.04
    FGP LTD. 12.16 202.67 4.23 14.46 7.32 12.75

    Evoq Remedies Limited shareholding pattern

    Holding
    99.98%
    0.01%
    Name Shares Category
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)

    News

    Left Arrow
    Right Arrow

    Evoq Remedies Limited Technicals Summary

    • EMA & SMA
    • Resistance and Support
    • Delivery and Volume
    • Beta
    • Price Change Analysis
    2.14 -4.88 redarrow
    red-green-graph indicator
    16 Bearish
    0 Bullish
    • 5 Days 2.30
    • 26 Days 2.50
    • 10 Days 2.30
    • 50 Days 2.70
    • 12 Days 2.30
    • 100 Days 3.00
    • 20 Days 2.50
    • 200 Days 3.40
    2.29 PIVOT
    First Support 2.26 First Resistance 2.33 Second Support 2.22 Second Resistance 2.36 Third Support 2.19 Third Resistance 2.40
    RSI 38.35 ADX 52.51 MACD -0.18 Williams % R -67.92 Commodity Channel Index (CCI) -99.54
    Date 2026-07-13 Week 71333.00 Same Day 56000.00 Month 85200.00
    1 Year 1.28 3 Year 0.78
    Over 1 Month
    -10.81% down
    Over 1 Year
    -50.53% down
    Over 3 Months
    -31.45% down
    Over 3 Years
    -45.78% down
    Over 6 Months
    -20.61% down
    Over 5 Years
    -37.25% down

    Evoq Remedies Limited Corporate Actions

    Top Gainers

    Top Losers

    stock
    Trade stocks with ease

    Sign-in to trade with your demat account, or set up a new demat account for free

    Board Of Directors

    Similar stocks

    Frequently Asked Questions

    What is the Current Share Price of Evoq Remedies Ltd?

    Answer Field

    Evoq Remedies Ltd share price is for NSE ₹ 0.00 & for BSE ₹ 2.14 as on Jul 15 2026 12:43 PM.

    What is the Market Cap of Evoq Remedies Ltd Share?

    Answer Field

    The market cap of Evoq Remedies Ltd for NSE ₹ 0.00 & for BSE ₹ 5.30 as on Jul 15 2026 12:43 PM.

    What is the 52 Week High and Low of Evoq Remedies Ltd?

    Answer Field

    The 52 Week High and Low of Evoq Remedies Ltd for NSE is ₹ 0.00 and ₹ 0.00 and for BSE is ₹ 6.11 and ₹ 2.14.

    What is 1 year return for Evoq Remedies Ltd?

    Answer Field

    The 1 year returns on the stock has been -51.82%.

    What is the P/E Ratio of Evoq Remedies Ltd Share?

    Answer Field

    As on Jul 15 2026 12:43 PM the price-to-earnings (PE) ratio for Evoq Remedies Ltd share is -22.50.

    What is the PB ratio of Evoq Remedies Ltd Share?

    Answer Field

    As on Jul 15 2026 12:43 PM, the price-to-book (PB) ratio for Evoq Remedies Ltd share is 17.79.

    How to Buy Evoq Remedies Ltd Share?

    Answer Field

    You can trade in Evoq Remedies Ltd shares with Bajaj Broking by opening a demat account.

    How to Buy Evoq Remedies Ltd Share on Bajaj Broking App?

    Answer Field

    To buy Evoq Remedies Ltd shares on the Bajaj Broking app, follow these steps:

    • Login to the Bajaj Broking App

    • Click on the Search Icon

    • Search “Evoq Remedies Ltd”

    • Click on the BUY icon

    • Place a buy order specifying the desired quantity of shares.

    • Click BUY again to complete the purchase

    No results found

    close-img
    Authorise with OTP
    Enter the 4-Digit OTP sent to
    edit
    OTP expires in 00:59
    banner-icon

    Open Your Free Demat Account

    Enjoy low brokerage on delivery trades

    +91

    |

    Open Your Free Demat Account

    Enjoy low brokerage on delivery trades

    +91

    |